Brussels, Belgium, September 27, 2018

Merodis, an independent corporate finance advisory firm, is pleased to announce that it successfully advised Mr. Vincent Leclercq, the CEO and sole shareholder of the RMN Group (http://www.rmnet.be/), on the trade sale to Vivactis.

Founded in 1989, the RMN Group (Reflexion Medical Network) is a Belgium-based group of companies specialised in B2B healthcare communication. RMN Group publishes 12 different science-based magazines/journals (digital and print with e-newsletters) which are targeted the medical specialists, general practitioners and pharmacists.

In support of these 12 “media brands”, RMN Group also provides the pharmaceutical industry with video production tools (for webinars, video capsules, training of sales reps, etc.), an accredited e-learning platform (Braintop®) and the organization of specialized business seminars.

The acquiring company, the Vivactis Group (http://www.vivactis.com/), is a leading international group of companies active in the healthcare consulting, communications and marketing areas.

For more information, please contact:

Rodolphe Blondiau
rbl@merodis.com, +32 488 81 45 07
Dirk Marckx
dma@merodis.com, +32 495 38 17 81